Insulet Research and Development Expenses 2010-2025 | PODD
Insulet annual/quarterly research and development expenses history and growth rate from 2010 to 2025. Research and development expenses can be defined as an expense arising from studies and product development processes.
- Insulet research and development expenses for the quarter ending March 31, 2025 were $0.060B, a 18.73% increase year-over-year.
- Insulet research and development expenses for the twelve months ending March 31, 2025 were $229M, a 11.65% increase year-over-year.
- Insulet annual research and development expenses for 2024 were $0.22B, a 7.12% increase from 2023.
- Insulet annual research and development expenses for 2023 were $0.205B, a 13.76% increase from 2022.
- Insulet annual research and development expenses for 2022 were $0.18B, a 12.55% increase from 2021.
| Insulet Annual Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2024 | $220 |
| 2023 | $205 |
| 2022 | $180 |
| 2021 | $160 |
| 2020 | $147 |
| 2019 | $132 |
| 2018 | $0 |
| 2017 | $76 |
| 2016 | $56 |
| 2015 | $43 |
| 2014 | $28 |
| 2013 | $22 |
| 2012 | $24 |
| 2011 | $22 |
| 2010 | $17 |
| 2009 | $13 |
| Insulet Quarterly Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2025-03-31 | $60 |
| 2024-12-31 | $61 |
| 2024-09-30 | $55 |
| 2024-06-30 | $54 |
| 2024-03-31 | $50 |
| 2023-12-31 | $42 |
| 2023-09-30 | $58 |
| 2023-06-30 | $55 |
| 2023-03-31 | $50 |
| 2022-12-31 | $50 |
| 2022-09-30 | $45 |
| 2022-06-30 | $43 |
| 2022-03-31 | $43 |
| 2021-12-31 | $42 |
| 2021-09-30 | $38 |
| 2021-06-30 | $40 |
| 2021-03-31 | $41 |
| 2020-12-31 | $38 |
| 2020-09-30 | $39 |
| 2020-06-30 | $34 |
| 2020-03-31 | $36 |
| 2019-12-31 | $36 |
| 2019-09-30 | $31 |
| 2019-06-30 | $33 |
| 2019-03-31 | $33 |
| 2018-12-31 | |
| 2018-09-30 | $22 |
| 2018-06-30 | $19 |
| 2018-03-31 | $20 |
| 2017-12-31 | $20 |
| 2017-09-30 | $20 |
| 2017-06-30 | $18 |
| 2017-03-31 | $18 |
| 2016-12-31 | $16 |
| 2016-09-30 | $14 |
| 2016-06-30 | $13 |
| 2016-03-31 | $13 |
| 2015-12-31 | $13 |
| 2015-09-30 | $10 |
| 2015-06-30 | $12 |
| 2015-03-31 | $8 |
| 2014-12-31 | $7 |
| 2014-09-30 | $7 |
| 2014-06-30 | $7 |
| 2014-03-31 | $7 |
| 2013-12-31 | $6 |
| 2013-09-30 | $6 |
| 2013-06-30 | $5 |
| 2013-03-31 | $4 |
| 2012-12-31 | $6 |
| 2012-09-30 | $7 |
| 2012-06-30 | $7 |
| 2012-03-31 | $5 |
| 2011-12-31 | $6 |
| 2011-09-30 | $5 |
| 2011-06-30 | $7 |
| 2011-03-31 | $5 |
| 2010-12-31 | $4 |
| 2010-09-30 | $4 |
| 2010-06-30 | $5 |
| 2010-03-31 | $4 |
| 2009-12-31 | $3 |
| 2009-09-30 | $3 |
| 2009-06-30 | $3 |
| 2009-03-31 | $3 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $21.421B | $2.072B |
| Insulet Corporation is a leading developer, manufacturer and marketer of the Omnipod Insulin Management System. The system is equipped with a self-adhesive, small and lightweight disposable tubeless Omnipod device along with the wireless and handheld Personal Diabetes Manager (PDM). The Omnipod System is an innovative, discreet and easy-to-use continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System consists of Omnipod Insulin Management System ('Omnipod') and the Omnipod DASH Insulin Management System - Insulet's next generation digital mobile Omnipod platform. Insulet has tied up with pharmaceutical and biotechnological companies using customized form of the Omnipod System to deliver a drug at a certain administered volume and over a specified period of time. Insulet has partnered with pharmaceutical and biotechnology companies to tailor the Omnipod System technology platform for the delivery of subcutaneous drugs across other therapeutic areas. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $230.146B | 27.67 |
| Boston Scientific (BSX) | United States | $150.504B | 37.68 |
| Stryker (SYK) | United States | $142.511B | 29.80 |
| EssilorLuxottica (ESLOY) | France | $130.598B | 0.00 |
| Medtronic (MDT) | Ireland | $110.517B | 15.67 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.287B | 0.00 |
| Haleon (HLN) | United Kingdom | $47.240B | 26.92 |
| ResMed (RMD) | United States | $36.670B | 27.54 |
| Agilent Technologies (A) | United States | $32.977B | 21.50 |
| GE HealthCare Technologies (GEHC) | United States | $32.574B | 15.47 |
| Terumo (TRUMY) | Japan | $26.206B | 34.04 |
| Koninklijke Philips (PHG) | Netherlands | $20.782B | 14.94 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.848B | 11.46 |
| Baxter (BAX) | United States | $15.354B | 11.46 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.539B | 0.00 |
| Demant (WILYY) | Denmark | $9.110B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.087B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.271B | 21.82 |
| Lantheus Holdings (LNTH) | United States | $5.391B | 13.60 |
| Prestige Consumer Healthcare (PBH) | United States | $4.135B | 18.47 |
| Perrigo (PRGO) | Ireland | $3.612B | 9.15 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.315B | 15.10 |
| ICU Medical (ICUI) | United States | $3.199B | 23.59 |
| Envista Holdings (NVST) | United States | $3.124B | 25.96 |
| GN Store Nord (GNNDY) | Denmark | $2.272B | 18.82 |
| QuidelOrtho (QDEL) | United States | $1.896B | 13.04 |
| LeMaitre Vascular (LMAT) | United States | $1.830B | 40.91 |
| AtriCure (ATRC) | United States | $1.614B | 0.00 |
| Acuren (TIC) | United States | $1.361B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.148B | 11.66 |
| Neogen (NEOG) | United States | $1.146B | 14.67 |
| Green Thumb Industries (GTBIF) | United States | $1.048B | 23.57 |
| BioLife Solutions (BLFS) | United States | $1.033B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.991B | 12.67 |
| InMode (INMD) | Israel | $0.845B | 8.52 |
| Kestra Medical Technologies (KMTS) | United States | $0.774B | 0.00 |
| CeriBell (CBLL) | United States | $0.641B | 0.00 |
| Evolus (EOLS) | United States | $0.596B | 0.00 |
| Owens & Minor (OMI) | United States | $0.583B | 4.83 |
| Capricor Therapeutics (CAPR) | United States | $0.557B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.549B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.532B | 0.00 |
| Valneva SE (VALN) | France | $0.500B | 0.00 |
| Surmodics (SRDX) | United States | $0.415B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.387B | 0.00 |
| SNDL (SNDL) | Canada | $0.336B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.331B | 58.80 |
| VAREX IMAGING (VREX) | United States | $0.320B | 11.77 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.307B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.261B | 22.00 |
| Sanuwave Health (SNWV) | United States | $0.256B | 0.00 |
| Cerus (CERS) | United States | $0.250B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.247B | 0.00 |
| ZimVie (ZIMV) | United States | $0.244B | 11.08 |
| Canopy Growth (CGC) | Canada | $0.243B | 0.00 |
| Quanterix (QTRX) | United States | $0.238B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.233B | 0.00 |
| Biote (BTMD) | United States | $0.215B | 6.05 |
| OraSure Technologies (OSUR) | United States | $0.210B | 0.00 |
| Brainsway (BWAY) | Israel | $0.208B | 54.95 |
| TriSalus Life Sciences (TLSI) | United States | $0.196B | 0.00 |
| Omeros (OMER) | United States | $0.188B | 0.00 |
| Organigram Global (OGI) | Canada | $0.184B | 0.00 |
| High Tide (HITI) | Canada | $0.182B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.181B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.175B | 14.28 |
| Exagen (XGN) | United States | $0.165B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.136B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.128B | 15.72 |
| Jin Medical (ZJYL) | China | $0.108B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| Fonar (FONR) | United States | $0.087B | 11.26 |
| MacroGenics (MGNX) | United States | $0.086B | 0.00 |
| Veru (VERU) | United States | $0.085B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.082B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.080B | 0.00 |
| Agape ATP (ATPC) | $0.076B | 0.00 | |
| Cytosorbents (CTSO) | United States | $0.075B | 0.00 |
| Zynex (ZYXI) | United States | $0.071B | 0.00 |
| InterCure (INCR) | Israel | $0.068B | 0.00 |
| Apyx Medical (APYX) | United States | $0.067B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.058B | 0.00 |
| ImmuCell (ICCC) | United States | $0.057B | 0.00 |
| Modular Medical (MODD) | United States | $0.043B | 0.00 |
| Nephros (NEPH) | United States | $0.040B | 54.00 |
| United-Guardian (UG) | United States | $0.038B | 12.97 |
| Rockwell Medical (RMTI) | United States | $0.031B | 0.00 |
| Safety Shot (SHOT) | United States | $0.020B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| Flora Growth (FLGC) | United States | $0.016B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.016B | 0.00 |
| INLIF (INLF) | $0.013B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.012B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Senestech (SNES) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |